| 标题 |
Sacituzumab tirumotecan (sac-TMT) vs investigator's clhoice of chemotherapy in previously treated locally advanced or metastatic Ihormone receptor-positive, HER2-negative (HR+/HER2-) breast cancerresults from the randomized, multi-center phase 3 OptiTROP-Breast02 stuady
Sacituzumab tirumotecan(sac-TMT)与研究者化疗在既往治疗过的局部晚期或转移性Ihormone受体阳性、HER2阴性(HR+/HER2-)乳腺癌中的疗效比较随机、多中心3期OptiTROP-Breast02研究的结果
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 |
Ying Fanl, Huihui Li2, Hao Wang3, Shusen Wang4, Haijun Yu5, Zhoongsheng Tong6, Zhengkui Sun7, Man Li8, Xiying Shao9, Yongmei Yin10, Quchang Ouyang11, Jian Liu12,Wenhui Wang13, Jiuwei Cui14, Kinhong Wu15, Gesha Liu16, Yina Diao16, Xiaoping Jin16, Juanyou Ge16, 17, Binghe Xul |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |